CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
Kyoung Min Cho, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo
Korean J Intern Med. 2015;30(6):891-898.   Published online 2015 October 30    DOI: https://doi.org/10.3904/kjim.2015.30.6.891

Excel Download

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
The Korean Journal of Internal Medicine. 2015;30(6):891-898   Crossref logo
Link1 Link2 Link3

Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case-control study
Thoracic Cancer. 2012;3(1):27-33   Crossref logo
Link1

Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Thoracic Cancer. 2013;4(2):109-116   Crossref logo
Link1

Brief report: Retrospective review of efficacy of erlotinib or gefitinib compared to docetaxel as subsequent line therapy in advanced non-small cell lung cancer (NSCLC) following failure of platinum-based chemotherapy
Lung Cancer. 2008;61(2):262-265   Crossref logo
Link1 Link2

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
Lung Cancer: Targets and Therapy. 2010;1   Crossref logo
Link1

Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations
Clinical Lung Cancer. 2016;17(5):412-418   Crossref logo
Link1 Link2

Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer
Lung Cancer. 2005;50(3):417-418   Crossref logo
Link1 Link2

ILD during Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer
Journal of Thoracic Oncology. 2010;5(11):1878   Crossref logo
Link1 Link2

ILD during Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer
Journal of Thoracic Oncology. 2010;5(11):1877-1878   Crossref logo
Link1 Link2

Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases
Lung Cancer International. 2012;2012:1-6   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.